Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet. 2021; 303:(2)337-345

Diriba K, Awulachew E, Getu E. The effect of coronavirus infection (SARS-CoV-2, MERS-CoV, and SARS-CoV) during pregnancy and the possibility of vertical maternal-fetal transmission: a systematic review and meta-analysis. Eur J Med Res. 2020; 25:(1)

Johansson MA, Quandelacy TM, Kada S SARS-Cov-2 transmission from people without COVID-19 symptoms. JAMA Netw Open. 2021; 4:(1)

Kourtis AP, Read JS, Jamieson DJ. Pregnancy and infection. N Engl J Med. 2014; 370:(23)2211-2218

Lee S, Meyler P, Mozel M, Tauh T, Merchant R. Asymptomatic carriage and transmission of SARS-CoV-2: What do we know?. Can J Anaesth. 2020; 67:(10)1424-1430

Marra P, Colacurcio V, Bisogno A Evaluation of discomfort in nasopharyngeal swab specimen collection for SARS-CoV-2 Diagnosis. Clin Ter. 2021; 172:(5)448-452

McDevitt K, Ganjoo N, Mlangeni D, Pathak S. Outcome of universal screening of neonates for COVID-19 from asymptomatic mothers. J Infect. 2020; 81:(3)452-482

Moisset X, Gautier N, Godet T Nasopharyngeal swab-induced pain for SARS-CoV-2 screening: a randomised controlled trial of conventional and self-swabbing. Eur J Pain. 2021; 25:(4)924-929

Rivett L, Sridhar S, Sparkes D Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife. 2020; 9

Schwartz DA, Graham AL. Potential maternal and infant outcomes from Coronavirus 2019-nCoV (SARS-CoV-2) infecting pregnant women: Lessons from SARS, MERS, and other human coronavirus infections. Viruses. 2020; 12:(2)

Wang S, Guo L, Chen L A case report of neonatal COVID-19 infection in China. Clin Infect Dis. 2020; 71:(15)853-857

World Health Organization. WHO Director-General's opening remarks at the media briefing on COVID-19 – 11 March 2020. 2020. (accessed 20 March 2021)

World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2022. (accessed 28 March 2022)

A mother's perspective of consent for maternal and neonatal COVID-19 testing: can we do more?

02 July 2022
12 min read
Volume 30 · Issue 7



There is ongoing research on the effects of COVID-19 on pregnancy and whether vertical viral transmission occurs.


This study aimed to determine maternal opinions of COVID-19 testing for pregnant women and newborns in order to influence future clinical practice while advancing global knowledge of the impact of testing on patient experiences.


This service evaluation assessed the opinions of 292 pregnant women who were tested for COVID-19 along with their newborn babies using nasopharyngeal swabs and the SARS-CoV-2 reverse transcription polymerase chain reaction test between 28 April and 21 May 2020.


Many women felt their own (60%) and their baby's (61%) swab was compulsory and did not feel sufficiently informed about the risks and benefits for themselves (43%) or their baby (52%) being tested. Some women did not understand the implications of a positive test for themselves (43%) or their baby (42%). Most participants reported they would agree to themselves (97%) and their baby (86%) being tested in future pregnancies.


Communication to pregnant women regarding the COVID-19 swabbing process is critical and requires improvement. This service evaluation highlighted where women felt under-informed. These areas should be covered in more detail for consenting women for COVID-19 testing in future.

After December 2019, when the first case of the novel 2019 coronavirus (SARS-CoV-2) was identified, the associated illness (COVID-19) became a significant international health concern. Declared a global pandemic by the World Health Organization (WHO, 2020) on 11 March 2020, COVID-19 remains one of the most catastrophic and unprecedented public health crises in decades. It resulted in over 534 million reported cases worldwide and 6.3 million deaths as of 16 June 2022 (WHO, 2022), with numbers continuing to rise as new strains with potentially more harmful effects are identified.

The impact of COVID-19 on pregnant women has been the cause of much controversy. The focus of current literature regarding this cohort of the population has been two-fold. Studies have either concentrated on the infection's effects on mother, baby and the pregnancy or evaluated the possibility of vertical transmission from a pregnant mother to her fetus in utero, during delivery or in the postpartum period. With regards to the former, several studies have highlighted that coronavirus infections lead to more severe complications and negative outcomes in pregnancy, including renal failure, disseminated intravascular coagulopathy, preterm deliveries, fetal growth restriction, a greater chance of intensive care admission, intubation and mechanical ventilation and spontaneous miscarriages, stillbirths or perinatal deaths (Schwartz and Graham, 2020). Normal physiological changes occurring during pregnancy are thought to underpin the rationale for pregnant women being more susceptible to developing these negative outcomes (Kourtis et al, 2014). Cardiopulmonary adaptations as a result of the gravid uterus predispose to hypoxaemia, while variations in sex hormone levels and their interaction with the immune system hinder pathogen elimination and exacerbate infection severity (Kourtis et al, 2014).

Register now to continue reading

Thank you for visiting British Journal of Midwifery and reading some of our peer-reviewed resources for midwives. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to our clinical or professional articles

  • New content and clinical newsletter updates each month